MDMA-Assisted Cognitive-Behavioral Conjoint Therapy (CBCT) in Dyads in Which 1 Member Has Chronic PTSD

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

12

Participants

Timeline

Start Date

July 3, 2016

Primary Completion Date

December 16, 2017

Study Completion Date

May 29, 2018

Conditions
Posttraumatic Stress Disorder
Interventions
DRUG

MDMA

Two sessions of MDMA-assisted therapy, one with an initial dose of 75 mg midomafetamine HCl (and optional supplemental dose of 37.5 mg) and the second with 75 or 100 mg midomafetamine HCl (with optional supplemental dose of either 37.5 mg or 50 mg respectively) given to the participant with PTSD and their significant other.

BEHAVIORAL

CBCT

A three-phase, 15-session, manualized treatment from the CBCT manual

BEHAVIORAL

Therapy

Manualized MDMA-assisted therapy

Trial Locations (1)

29464

Offices of Michael Mithoefer MD, Mt. Pleasant

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Lykos Therapeutics

INDUSTRY